SCM
MIRM icon

Silverarc Capital Management’s Mirum Pharmaceuticals MIRM Stock Holding History

Silverarc Capital Management’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-79,194
Closed -$2.71M – 79
2024
Q2 		$2.71M Hold
79,194
– – 0.64% 40
2024
Q1 		$1.99M Sell
79,194
-1,617
-2% -$44.5K 0.55% 50
2023
Q4 		$2.39M Sell
80,811
-29,303
-27% -$887K 0.71% 44
2023
Q3 		$3.48M Buy
110,114
+3,739
+4% +$102K 1.06% 38
2023
Q2 		$2.75M Buy
106,375
+436
+0.4% +$11.6K 0.85% 41
2023
Q1 		$2.54M Buy
+105,939
New +$2.41M 1.05% 36

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Silverarc Capital Management's MIRM Position: Q3 2024 in Review

Silverarc Capital Management sold out of Mirum Pharmaceuticals (MIRM) in Q3 2024, closing a stake of 79,194 shares — an estimated $2.71M sold.

Silverarc Capital Management first reported a position in MIRM in Q1 2023 and held it in 6 quarters. The position peaked at $3.48M in Q3 2023. 178 funds tracked by Wall St. Rank hold MIRM as of Q3 2024.

  • Silverarc Capital Management reported no remaining Mirum Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Silverarc Capital Management sold 79,194 Mirum Pharmaceuticals shares in Q3 2024, an estimated $2.71M.
  • Silverarc Capital Management first reported a position in Mirum Pharmaceuticals in Q1 2023 and held it in 6 quarters.
  • Silverarc Capital Management's Mirum Pharmaceuticals position peaked at $3.48M in Q3 2023.
  • 178 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q3 2024.

Based on Silverarc Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.